We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Medtronic to Buy Chinese Medical Device Kanghui

By HospiMedica International staff writers
Posted on 09 Oct 2012
Medtronic Inc (Fridley, MN, USA), the world's largest stand-alone maker of medical devices, has agreed to buy orthopedic device maker China Kanghui Holdings (Kanghui; Changzhou, China), in a bid to enter the Chinese medical device market.

The USD 816 million acquisition will provide Medtronic sustainable advantages in the fast-growing Chinese orthopedic segment, as well as a foothold in the emerging global value segment in orthopedics. Kanghui brings to Medtronic a strong product portfolio and new product pipeline in trauma, spine, and joint reconstruction. The combined portfolio expands Medtronic's offerings in orthopedic surgery and complements the company's existing presence in spine, neurosurgery, neuromodulation, advanced energy, and surgical navigation.

“This agreement is directly aligned with our corporate strategies of globalization and economic value,” said Omar Ishrak, chairman and CEO of Medtronic. “Kanghui represents a significant investment in China, accelerating Medtronic's overall globalization strategy with an established value segment distribution network and strong R&D and operational capabilities.”

“We are proud of the company we've built and recognize there is a tremendous opportunity to accelerate our global vision by building on Medtronic's size, scale and expertise as part of this combined organization,” said Libo Yang, CEO of Kanghui. “We look forward to bringing to Medtronic our local operating expertise in China, including our wide distribution network, strong local sales and marketing teams, local manufacturing and R&D, as well as our active presence across a number of value orthopedic product lines that are necessary for success in China and other emerging markets.”

Medtronic has spent more than USD 2.6 billion on overseas acquisitions, including a USD 221 million deal for a 15% stake in Shandong Weigao Group Medical Polymer (Weihai, China) in 2007, at the time the biggest maker of medical devices in China.

Related Links:

Medtronic Inc.
China Kanghui Holdings
Shandong Weigao Group Medical Polymer



New
Gold Member
X-Ray QA Meter
T3 AD Pro
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Blanket Warming Cabinet
EC250
New
Pneumatic Stool
Avante 5-Leg Pneumatic Stool

Latest Business News

MEDICA 2024 to Highlight Hot Topics of MedTech Industry

Start-Ups To Once Again Play Starring Role at MEDICA 2024

Boston Scientific to Acquire AFib Ablation Company Cortex